MedTrace Logo

Spectroscopy From Duodenum

NCT01753479 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 445

Last updated 2017-03-07

No results posted yet for this study

Summary

Purpose of this study is to understand the clinical feasibility of duodenal spectroscopy to adenocarcinoma patients.

Conditions

  • Pancreatic Adenocarcinoma

Interventions

OTHER

Spectroscopy device

Spectrum data are collected using spectroscopy device via an instrumental channel of endoscope. Then spectrum data is analyzed. Numerical features (spectral slope and width of spectrum) are used for statistical analysis.

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • Catholic University of the Sacred Heart

    collaborator OTHER

  • Erasme University Hospital

    collaborator OTHER

  • Olympus Corporation

    lead INDUSTRY

Principal Investigators

  • Michael B Wallace, M.D. · Mayo Clinic

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States
  • Belgium
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01753479 on ClinicalTrials.gov